ArticleBlood advances2026
Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.